Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lewis Karen Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 5,000 shares @ $86, valued at $430k
Exercised 5,000 options to buy @ $34.11, valued at $170.6k
04/05/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 5,000 shares @ $75, valued at $375k
Exercised 5,000 options to buy @ $34.11, valued at $170.6k
02/27/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 1,104 shares @ $68.76, valued at $75.9k
02/22/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 6,628 shares @ $0
Paid exercise price by delivering 553 shares @ $58.5, valued at $32.4k
Granted 9,402 options to buy @ $35.46, valued at $333.4k
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 367 shares @ $52.77, valued at $19.4k
01/25/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 2,955 shares @ $51.58, valued at $152.4k
01/24/2023 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 1,411 shares @ $52.05, valued at $73.4k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 434 shares @ $38.59, valued at $16.7k
01/25/2022 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 17,466 shares @ $0
Granted 24,774 options to buy @ $35.46, valued at $878.5k
02/01/2021 4 Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 5,000 shares @ $0
Granted 1,250 shares @ $0
Granted 30,000 options to buy @ $44.9, valued at $1.3M
Granted 7,500 options to buy @ $44.9, valued at $336.8k
06/09/2020 3 Lewis Karen (Chief People Officer) has filed a Form 3 on Apellis Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy